Dar� Bioscience, Inc.

Dare Bioscience Inc. is a clinical-stage biopharmaceutical company dedicated to advancing healthcare opportunities in the field of women’s reproductive health. The primary focus of the company is to develop innovative products that address a variety of conditions and prioritize unmet needs in women's sexual health, with a range of initiatives targeting fertility, contraception, and vaginal health. Notable features of Dare Bioscience's portfolio include hormonal and non-hormonal therapies, inventive contraceptive solutions, and treatments for pelvic conditions. Operating within the dynamic biopharmaceutical sector, Dare Bioscience plays a significant role in fostering advancements through its partnership and research collaborations across the globe. The company’s strategic efforts aim to deliver both novel and effective healthcare solutions that potentially improve quality of life and generate impactful outcomes for women. Dare Bioscience's commitment to innovation highlights its market significance, as it seeks to address broad and underserved areas of women's health care.